167 related articles for article (PubMed ID: 17467579)
21. Effect of mergers and acquisitions on drug discovery: perspective from a case study of a Japanese pharmaceutical company.
Shibayama S; Tanikawa K; Fujimoto R; Kimura H
Drug Discov Today; 2008 Jan; 13(1-2):86-93. PubMed ID: 18190869
[TBL] [Abstract][Full Text] [Related]
22. [Some thoughts on therapeutic research].
Potier P
Ann Pharm Fr; 2000 Jul; 58(4):225-7. PubMed ID: 10915968
[TBL] [Abstract][Full Text] [Related]
23. How should we support pharmaceutical innovation?
Grootendorst P
Expert Rev Pharmacoecon Outcomes Res; 2009 Aug; 9(4):313-20. PubMed ID: 19670991
[TBL] [Abstract][Full Text] [Related]
24. The Biomarkers Consortium: on the critical path of drug discovery.
Altar CA
Clin Pharmacol Ther; 2008 Feb; 83(2):361-4. PubMed ID: 18183037
[TBL] [Abstract][Full Text] [Related]
25. To measure is to know: an approach to CADD performance metrics.
Loughney D; Claus BL; Johnson SR
Drug Discov Today; 2011 Jul; 16(13-14):548-54. PubMed ID: 21605697
[TBL] [Abstract][Full Text] [Related]
26. Reducing systems biology to practice in pharmaceutical company research; selected case studies.
Benson N; Cucurull-Sanchez L; Demin O; Smirnov S; van der Graaf P
Adv Exp Med Biol; 2012; 736():607-15. PubMed ID: 22161355
[TBL] [Abstract][Full Text] [Related]
27. The difficulties industry is facing with investigators.
Blackledge GR
Eur J Cancer; 2005 Oct; 41(15):2210-2. PubMed ID: 16214043
[TBL] [Abstract][Full Text] [Related]
28. The prospects for "personalized medicine" in drug development and drug therapy.
Woodcock J
Clin Pharmacol Ther; 2007 Feb; 81(2):164-9. PubMed ID: 17259943
[TBL] [Abstract][Full Text] [Related]
29. Clinical Biomarkers Forum: harnessing the potential of biomarkers from translational research throughout clinical trials.
Shaw M
Expert Rev Mol Diagn; 2007 Nov; 7(6):759-60. PubMed ID: 18020905
[No Abstract] [Full Text] [Related]
30. Impact of non-profit organizations on drug discovery: opportunities, gaps, solutions.
Matter A; Keller TH
Drug Discov Today; 2008 Apr; 13(7-8):347-52. PubMed ID: 18405848
[TBL] [Abstract][Full Text] [Related]
31. Stratified medicine: strategic and economic implications of combining drugs and clinical biomarkers.
Trusheim MR; Berndt ER; Douglas FL
Nat Rev Drug Discov; 2007 Apr; 6(4):287-93. PubMed ID: 17380152
[TBL] [Abstract][Full Text] [Related]
32. Novel biomarkers of acute kidney toxicity.
Goodsaid FM; Blank M; Dieterle F; Harlow P; Hausner E; Sistare F; Thompson A; Vonderscher J
Clin Pharmacol Ther; 2009 Nov; 86(5):490-6. PubMed ID: 19710639
[TBL] [Abstract][Full Text] [Related]
33. Biomarkers for TB treatment response: challenges and future strategies.
Walzl G; Ronacher K; Djoba Siawaya JF; Dockrell HM
J Infect; 2008 Aug; 57(2):103-9. PubMed ID: 18649943
[TBL] [Abstract][Full Text] [Related]
34. [Strategy of molecular drug design: hits, leads and drug candidates].
Guo ZR
Yao Xue Xue Bao; 2008 Sep; 43(9):898-904. PubMed ID: 19048779
[TBL] [Abstract][Full Text] [Related]
35. A six-sigma approach to stability testing.
De Vore K
J Pharm Biomed Anal; 2008 Jun; 47(2):413-21. PubMed ID: 18262382
[TBL] [Abstract][Full Text] [Related]
36. Metabolomics in pharmaceutical research and development: metabolites, mechanisms and pathways.
Xu EY; Schaefer WH; Xu Q
Curr Opin Drug Discov Devel; 2009 Jan; 12(1):40-52. PubMed ID: 19152212
[TBL] [Abstract][Full Text] [Related]
37. Helping science to succeed: improving processes in R&D.
Sewing A; Winchester T; Carnell P; Hampton D; Keighley W
Drug Discov Today; 2008 Mar; 13(5-6):227-33. PubMed ID: 18342798
[TBL] [Abstract][Full Text] [Related]
38. Value networks identify innovation in 21st century pharmaceutical research.
Edwards PJ
Drug Discov Today; 2009 Jan; 14(1-2):68-77. PubMed ID: 18973823
[TBL] [Abstract][Full Text] [Related]
39. Does human pharmacokinetic prediction add significant value to compound selection in drug discovery research?
Beaumont K; Smith DA
Curr Opin Drug Discov Devel; 2009 Jan; 12(1):61-71. PubMed ID: 19152214
[TBL] [Abstract][Full Text] [Related]
40. Retrospective clinical analysis for drug rescue: for new indications or stratified patient groups.
Cavalla D; Singal C
Drug Discov Today; 2012 Feb; 17(3-4):104-9. PubMed ID: 22001144
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
